{4 (1 ML risankizumab-rzaa 90 MG/ML Prefilled Syringe) } Pack — RxCUI 2633001
RxNorm drug concept · Generic pack
RxCUI 2633001
Generic pack · GPCK
Retired or remapped concept 10 FDA products
16 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2633001
Official name{4 (1 ML risankizumab-rzaa 90 MG/ML Prefilled Syringe) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusRetired or remapped concept
FDA products mapped10
Package NDCs mapped16
Reported Medicaid activity (SDUD)82,904 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web
No related-concept groups were available for this RxCUI in the loaded RxNorm data. That does not prove that no related concepts exist.
📦 FDA Products & Package NDCs
10 products · 16 package NDCs
16 package NDCs map to RxCUI 2633001 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00074-1050-01 | 1 SYRINGE in 1 CARTON (0074-1050-01) / 1 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2021-04-26 |
| 00074-1050-70 | 1 SYRINGE in 1 CARTON (0074-1050-70) / 1 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2021-04-26 |
| 00074-1065-01 | 1 KIT in 1 CARTON (0074-1065-01) * 1.2 mL in 1 CARTRIDGE (... | Skyrizi | AbbVie Inc. | 2022-09-23 |
| 00074-1065-02 | 1 KIT in 1 CARTON (0074-1065-02) * 1.2 mL in 1 CARTRIDGE (... | Skyrizi | AbbVie Inc. | 2022-09-23 |
| 00074-1070-01 | 1 KIT in 1 CARTON (0074-1070-01) * 2.4 mL in 1 CARTRIDGE (... | Skyrizi | AbbVie Inc. | 2022-06-16 |
| 00074-1070-02 | 1 KIT in 1 CARTON (0074-1070-02) * 2.4 mL in 1 CARTRIDGE (... | Skyrizi | AbbVie Inc. | 2022-06-16 |
| 00074-2100-01 | 1 SYRINGE in 1 CARTON (0074-2100-01) / 1 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2021-04-26 |
| 00074-2100-70 | 1 SYRINGE in 1 CARTON (0074-2100-70) / 1 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2021-04-26 |
| 00074-4059-01 | 1 SYRINGE, GLASS in 1 CARTON (0074-4059-01) / .37 mL in 1 S... | Skyrizi | AbbVie Inc. | 2026-06-12 |
| 00074-4059-71 | 1 SYRINGE, GLASS in 1 CARTON (0074-4059-71) / .37 mL in 1 S... | Skyrizi | AbbVie Inc. | 2026-06-12 |
| 00074-5015-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-5015-01) / 10 mL in 1... | Skyrizi | AbbVie Inc. | 2022-06-16 |
| 00074-5015-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-5015-02) / 10 mL in 1... | Skyrizi | AbbVie Inc. | 2022-06-16 |
| 00074-7040-02 | 2 CARTON in 1 CARTON (0074-7040-02) / 1 KIT in 1 CARTON *... | Skyrizi | AbbVie Inc. | 2024-03-04 |
| 00074-7042-04 | 4 CARTON in 1 CARTON (0074-7042-04) / 1 KIT in 1 CARTON *... | Skyrizi | AbbVie Inc. | 2024-03-04 |
| 00074-8300-01 | 1 SYRINGE in 1 CARTON (0074-8300-01) / 1.2 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2025-09-03 |
| 00074-8350-01 | 2 SYRINGE in 1 CARTON (0074-8350-01) / 1.2 mL in 1 SYRINGE | Skyrizi | AbbVie Inc. | 2025-09-03 |
Observed labelers:
AbbVie Inc. (16)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2327 | Inj risankizumab-rzaa 1 mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.